Michael Brooks
President presso EDESA BIOTECH, INC.
Patrimonio netto: 74 068 $ in data 31/03/2024
Profilo
Michael Brooks is currently the President at Edesa Biotech, Inc. He previously worked as the Director of Business Development at Cipher Pharmaceuticals, Inc. from 2010 to 2015.
He also held positions at Edesa Biotech, Inc. (Old) and Edesa Biotech Research, Inc. In terms of education, Dr. Brooks holds an MBA from the Rotman School of Management and undergraduate and doctorate degrees from the University of Toronto.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EDESA BIOTECH, INC.
0.56% | 02/04/2024 | 17 669 ( 0.56% ) | 74 068 $ | 31/03/2024 |
Posizioni attive di Michael Brooks
| Società | Posizione | Inizio |
|---|---|---|
| EDESA BIOTECH, INC. | President | 07/06/2019 |
Precedenti posizioni note di Michael Brooks
| Società | Posizione | Fine |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2015 |
| Edesa Biotech Research, Inc. | Corporate Officer/Principal | - |
Edesa Biotech, Inc. (Old)
 Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | President | - |
Formazione di Michael Brooks
| Rotman School of Management | Masters Business Admin |
| University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
| Edesa Biotech, Inc. | |
| Edesa Biotech Research, Inc. |
- Borsa valori
- Insiders
- Michael Brooks
